ArticleChemistry & biodiversity2026
Integrated Morphoanatomical, Phytochemical, and Bioactive Insights Into the Ethnomedicinal Plant Daphniphyllum neilgherrense.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Daphniphyllum neilgherrense (Daphniphyllaceae), an ethnomedicinal plant, is used for skin diseases and various ailments, for which the studies on its anatomical, phytochemical and pharmacological properties are unexplored. Hence, the present study has been aimed to explore anatomical, phytochemical, antimicrobial, antioxidant, and anticancer activities. The anatomy of different parts of the plant is elaborated for the first time. Antibacterial activity observed (inhibition zone) against Gram-positive bacteria (Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli) was 18.10 ± 0.22 and 16.23 ± 0.15 mm, respectively, while the antifungal activity against Candida albicans was 17.41 ± 0.16 mm. Minimum inhibitory concentration of D. neilgherrense aqueous extract against tested bacterial species varied between 0.250 and 1.00 mg/mL, while it was 2.00 and 4.00 mg/mL for fungal species. Antioxidant potential (IC
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.